4//SEC Filing
Rimac Anthony M 4
Accession 0001104659-23-082730
CIK 0001400118other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:18 PM ET
Size
8.0 KB
Accession
0001104659-23-082730
Insider Transaction Report
Form 4
Rimac Anthony M
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-18+242,142→ 242,142 totalExercise: $13.51Exp: 2033-04-19→ Series A Common Stock (242,142 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-18−242,142→ 0 totalExercise: $13.51Exp: 2033-04-19→ Common Stock (242,142 underlying)
Footnotes (2)
- [F1]Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.
- [F2]25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001604562
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:18 PM ET
- Size
- 8.0 KB